These are independent reviews of the products mentioned, but TIME receives a commission when purchases are made through affiliate links at no additional cost to the purchaser.
Ever since the first hamburger grown from bovine stem cells was unveiled in 2013, with a €250,000 price tag (around $280,000), biotechnologists have raced to produce an affordable alternative that tastes the same as meat, no slaughter—and fewer emissions—required. Startup Good Meat surged ahead when it launched its bioreactor-cultivated chicken morsels in Singapore in 2020, but rival Upside Foods wasn’t far behind. On June 21, the U.S. Department of Agriculture authorized both companies to sell cultivated meat in the U.S. Now that they are no longer vying for first, the companies can compete on taste and price.
More Must-Reads From TIME
- The 100 Most Influential People of 2024
- How Far Trump Would Go
- Scenes From Pro-Palestinian Encampments Across U.S. Universities
- Saving Seconds Is Better Than Hours
- Why Your Breakfast Should Start with a Vegetable
- 6 Compliments That Land Every Time
- Welcome to the Golden Age of Ryan Gosling
- Want Weekly Recs on What to Watch, Read, and More? Sign Up for Worth Your Time